Lemborexant + Placebo
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Sleep Initiation and Maintenance Disorders
Conditions
Sleep Initiation and Maintenance Disorders
Trial Timeline
Nov 6, 2020 → Mar 17, 2023
NCT ID
NCT04549168About Lemborexant + Placebo
Lemborexant + Placebo is a phase 3 stage product being developed by Eisai for Sleep Initiation and Maintenance Disorders. The current trial status is completed. This product is registered under clinical trial identifier NCT04549168. Target conditions include Sleep Initiation and Maintenance Disorders.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (4)
| NCT ID | Phase | Status |
|---|---|---|
| NCT07384429 | Approved | Recruiting |
| NCT06874855 | Approved | Recruiting |
| NCT04549168 | Phase 3 | Completed |
| NCT02952820 | Phase 3 | Completed |
Competing Products
20 competing products in Sleep Initiation and Maintenance Disorders